Hepatitis C: Clinical Trials

302 trials for Hepatitis C, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

190 completed, 53 unknown, 19 terminated, 11 recruiting. 302 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable302Completed 190, Unknown 53, Terminated 19, Recruiting 11, Not yet recruiting 9, Active not recruiting 8, Withdrawn 8, Enrolling by invitation 2, Suspended 2

Follow Hepatitis C: new trials by email Literature Review of Hepatitis C trials Research Report on Hepatitis C

Trials (filtered) newest first · largest first

All 302 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Integrated care - Opioid Use Disorder, HIV
Not applicableNot yet recruitingVA Office of Research and Development602028-04-032026-04-24
STRIVES: Status-Neutral TeleHealth Concierge Intervention for Unhoused People Who Use Drugs Via Engagement Through Street Medicine
Standard of Care (Patient Navigation to Off-Site Clinic), Status-Neutral Telehealth Concierge (SN-THR) - HIV, Substance Use Disorder (SUD)
Not applicableNot yet recruitingUniversity of Miami2002027-05-012026-11-12
ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing
Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid) - Hepatitis C
Not applicableNot yet recruitingJohns Hopkins University2002026-11-012025-11-10
Clinical Study to Evaluate the Performance of the INSTI® HCV Antibody Test for CLIA-Waived Use
INSTI HCV Antibody Test - HCV Infection
Not applicableNot yet recruitingbioLytical Laboratories3882026-11-012026-10-29
Study to Evaluate the Performance of the INSTI® HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV Infection
INSTI HCV Antibody Test - HCV Infection
Not applicableNot yet recruitingbioLytical Laboratories16602026-11-012026-10-29
Strengthening, Guidance, Health, Empowerment
Self-sampling for six sexually transmitted infections - HIV Infection, Syphilis
Not applicableNot yet recruitingUniversity Hospital, Montpellier2002026-09-012026-08-26
Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs
Partner navigation intervention booster session - HEPATITIS C (HCV), Opioid Use Disorder
Not applicableNot yet recruitingUniversity of California, San Francisco502026-09-012026-06-08
Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)
Telehealth Behavioral Intervention for promoting HIV and HCV care and MOUD among Persons who inject drugs (PWID) - HIV Pre-exposure Prophylaxis, HEPATITIS C (HCV)
Not applicableNot yet recruitingUniversity of Georgia502026-08-012025-12-18
Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing
PPP-CCM - HEPATITIS C (HCV)
Not applicableRecruitingUniversity of Washington4442026-06-012026-11-12
Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer
PIVKA-II and GAAD score calculation - Liver Cirrhosis, Hepatitis B, Chronic
Not applicableEnrolling by invitationSiriraj Hospital21002026-02-022026-04-24
California MEPS Hub
Mobile Enhanced Prevention Support (MEPS), Control - HIV Prevention, Sexually Transmitted Infections (STI)
Not applicableRecruitingUniversity of California, Los Angeles3182025-12-012026-04-03
Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).
resveratrol, quercetin, taurine, whey protein, and inulin, whey protein - Liver Disease Chronic, HEPATITIS C VIRUS CHRONIC INFECTION
Not applicableRecruitingUniversity of Guadalajara262025-10-112026-03-23
Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France
Community screening for hepatitis B, C and delta in the Mongolian population living in France - HEPATITIS C (HCV), Hepatitis B Virus (HBV)
Not applicableNot yet recruitingHospices Civils de Lyon20002025-09-012025-06-26
Hepatitis C Tracker Study
GPS tracker device - Hepatitis C Virus Infection
Not applicableRecruitingUniversity of Southern California1242025-08-082025-08-29
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
DBS TaT, Usual Care - Hepatitis C
Not applicableActive not recruitingOregon Health and Science University1412025-01-222026-06-05
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
MATCHES - Colorectal Cancer Screening, Hepatitis C Virus
Not applicableRecruitingH. Lee Moffitt Cancer Center and Research Institute3502024-10-212026-09-16
Lay User Evaluation of the Panbio™ HCV Self-Test
Panbio™ HCV Self Test - HEPATITIS C (HCV)
Not applicableUnknownAbbott Rapid Dx11852024-10-012024-09-20
Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons
NIATx - HIV, Hepatitis C Virus (HCV)
Not applicableRecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre5482024-10-012025-12-29
Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C
MagIA IBC test in capillary blood, MagIA IBC test in other blood matrices - Combined Point of Care Diagnostic of HIV, HBV and HCV
Not applicableTerminatedMagIA Diagnostics962024-09-162026-09-11
Hepatitis C Treatment in Idaho County Jails
sofosbuvir/velpatasvir - Hepatitis C
Not applicableUnknownEastern Idaho Public Health1002024-08-012024-08-01

Showing 20 of 302. Sign in to see all of them.

Narrower conditions

Hepatitis C, Chronic (55)  ·  Hepatitis B (29)  ·  Acquired Immunodeficiency Syndrome (25)  ·  Substance-Related Disorders (25)  ·  HIV Infections (23)  ·  Opioid-Related Disorders (17)  ·  Fibrosis (13)  ·  Liver Diseases (12)  ·  Carcinoma, Hepatocellular (10)  ·  Depression (10)  ·  Hepatitis (10)  ·  Liver Cirrhosis (7)  ·  Alcoholism (6)  ·  Medication Adherence (6)

Broader conditions

Blood-Borne Infections (302)  ·  Flaviviridae Infections (302)  ·  Digestive System Diseases (301)  ·  RNA Virus Infections (301)  ·  Communicable Diseases (300)  ·  Virus Diseases (300)  ·  Hepatitis, Viral, Human (299)  ·  Infections (298)  ·  Hepatitis (292)  ·  Liver Diseases (290)  ·  Pathological Conditions, Signs and Symptoms (96)  ·  Pathologic Processes (92)  ·  Disease Attributes (73)  ·  Chronic Disease (63)  ·  Urogenital Diseases (61)

Interventions

Ribavirin (23)  ·  peginterferon alfa-2a (11)  ·  Sofosbuvir (8)  ·  Standard of Care (7)  ·  Blood Specimen Collection (5)  ·  daclatasvir (5)  ·  Motivational Interviewing (4)  ·  Telemedicine (4)  ·  peginterferon alfa-2b (4)  ·  sofosbuvir-velpatasvir drug combination (4)  ·  Control Groups (3)  ·  Early Intervention, Educational (3)  ·  Ethanol (3)  ·  Interferons (3)  ·  N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide (3)

Sponsors

Kirby Institute (8)  ·  Foundation for Innovative New Diagnostics, Switzerland (7)  ·  Johns Hopkins University (7)  ·  VA Office of Research and Development (7)  ·  US Department of Veterans Affairs (6)  ·  University of La Laguna (6)  ·  Macfarlane Burnet Institute for Medical Research and Public Health Ltd (5)  ·  National Taiwan University Hospital (5)  ·  University of California, Los Angeles (5)  ·  University of California, San Francisco (5)  ·  ANRS, Emerging Infectious Diseases (4)  ·  Hasselt University (4)  ·  Icahn School of Medicine at Mount Sinai (4)  ·  Prisma Health-Upstate (4)  ·  University of Colorado, Denver (4)

Countries

United States (148)  ·  France (19)  ·  Australia (13)  ·  Canada (12)  ·  Spain (12)  ·  Egypt (9)  ·  Taiwan (9)  ·  United Kingdom (7)  ·  Belgium (6)  ·  Brazil (5)  ·  China (5)  ·  Israel (5)  ·  Thailand (5)  ·  Georgia (4)  ·  Germany (4)

Top investigators

Adeline Nyamathi, PhD (2)  ·  Alain Litwin, MD (2)  ·  Alain Litwin, MD, MPH (2)  ·  Ali Ismail, lecturer (2)  ·  Amy Silberbogen, PhD (2)  ·  Frederick L Altice, MD (2)  ·  Geert Robaeys, prof. dr. (2)  ·  Jason Haukoos, MD, MSc (2)  ·  Jennifer J Kiser, PharmD (2)  ·  Jennifer Kiser, PharmD (2)  ·  Jens Rosenau, MD (2)  ·  Kristen Marks (2)  ·  Manuel Hernandez-Guerra, MD (2)  ·  Mark Sulkowski, MD (2)  ·  Rob Bielen, dr. (2)

Results publications

PMID 10761562, PMID 10921388, PMID 10965678, PMID 11059069, PMID 11059125, PMID 11413125, PMID 12450640, PMID 12618532, PMID 12761382, PMID 12823087, PMID 15560058, PMID 15637534, PMID 15784668, PMID 16122679, PMID 17410291, PMID 17451562, PMID 17552026, PMID 17695343, PMID 17980513, PMID 18233994, PMID 18495540, PMID 18807097, PMID 19638084, PMID 19897823, PMID 20091629, PMID 20332290, PMID 20479894, PMID 20491973, PMID 20529203, PMID 20608766, PMID 20638216, PMID 21218306, PMID 21241735, PMID 21301463, PMID 21767252, PMID 21782772, PMID 21911884, PMID 22078241, PMID 22419935, PMID 23059806, PMID 23155727, PMID 23241251, PMID 23300053, PMID 23333451, PMID 23445604, PMID 23607593, PMID 23607594, PMID 23750991, PMID 24428467, PMID 24782620

NIH funding

P30AI042853 (2), 1IK2CX002822-01A1 (1), 1UL1TR001430 (1), 2008 (1), 4UH3DA044798-03 (1), 4UH3DA044829-03 (1), DP2DA053720 (1), I50HX002903 (1), K01DA059329 (1), K23AA023753 (1), K23DA022454 (1), K23DA039060 (1), K23DK089004 (1), K24DA061103 (1), K24DK066144 (1)